Bioasis to Present at Upcoming Industry Conferences
posted on
Jan 07, 2020 10:13AM
Bioasis to Present at Upcoming Industry Conferences
https://www.bioasis.us/bioasis-to-present-at-upcoming-industry-conferences/
Jan. 6, 2020, GUILFORD, Conn. GUILFORD, Conn.–(Business Wire)– Bioasis Technologies, Inc . (OTCQB:BIOAF; TSX.V:BTI), (the “Company” or “Bioasis”), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3™ platform technology for the delivery of therapeutics across the blood-brain barrier (“BBB”) and the treatment of central nervous system (“CNS”) disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases, today announced that Dr. Deborah Rathjen, Executive Chair and Chief Executive Officer of Bioasis will present at the following industry conferences:
3 rd Annual Neuroscience Innovation Forum for Business Development, Licensing and Investment. (https://www.sachsforum.com/3nif-about.html)
Biotech Showcase TM . (https://informaconnect.com/biotech-showcase/)
Follow us on: